These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37531863)

  • 1. NLRC5 potentiates anti-tumor CD8
    Zhang J; Guo B; Chen JH; Liu XJ; Zhang JH; Zhu HQ; Wang WY; Tang ZH; Wei B; Cao YX; Zhan L
    Transl Oncol; 2023 Oct; 36():101742. PubMed ID: 37531863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer.
    Zhan L; Zhang J; Zhang JH; Liu XJ; Guo B; Chen JH; Tang ZH; Wang WY; Wang QY; Wei B; Cao YX
    Biomark Res; 2023 Apr; 11(1):43. PubMed ID: 37085864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRC5 promotes endometrial carcinoma progression by regulating NF-κB pathway-mediated mismatch repair gene deficiency.
    Liu X; Zhu H; Guo B; Chen J; Zhang J; Wang T; Zhang J; Shan W; Zou J; Cao Y; Wei B; Zhan L
    Sci Rep; 2024 May; 14(1):12447. PubMed ID: 38822039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective autophagy of NLRC5 promotes immune evasion of endometrial cancer.
    Zhan L; Zhang J; Wei B; Cao Y
    Autophagy; 2022 Apr; 18(4):942-943. PubMed ID: 35174769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLRC5 deficiency has a moderate impact on immunodominant CD8
    Sun T; Ferrero RL; Girardin SE; Gommerman JL; Philpott DJ
    Immunol Cell Biol; 2019 Jul; 97(6):552-562. PubMed ID: 30768806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus Porcine Deltacoronavirus Upregulates MHC Class I Expression through RIG-I/IRF1-Mediated NLRC5 Induction.
    Liu X; Yin L; Xue M; Chen J; Li L; Fu F; Feng L; Liu P
    J Virol; 2022 Apr; 96(7):e0015822. PubMed ID: 35311551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC3 and NLRC5 interaction inhibits NLRC5-mediated MHC class I antigen presentation pathway in endometrial cancer.
    Zhan L; Zhang J; Zhang J; Liu X; Zhu S; Shi Y; He Y; Wang W; Fan Y; Tang Z; Chen G; Wei B; Cao Y
    Cancer Lett; 2022 Mar; 529():37-52. PubMed ID: 34974132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens.
    Rodriguez GM; Yakubovich E; Murshed H; Maranda V; Galpin KJC; Cudmore A; Hanna AMR; Macdonald E; Ramesh S; Garson K; Vanderhyden BC
    Front Immunol; 2023; 14():1295208. PubMed ID: 38235131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8
    Lupfer CR; Stokes KL; Kuriakose T; Kanneganti TD
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Major Histocompatibility Complex Class I-Related Functions of NLRC5.
    Chelbi ST; Dang AT; Guarda G
    Adv Immunol; 2017; 133():89-119. PubMed ID: 28215281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircATXN7 regulates the proliferation and invasion of esophageal cancer cells through miR-4319/NLRC5.
    Guo L; Wang M; Zhao W; Guo M; Qian T; Peng F; Cao G; Yu S; Liu D
    Cell Signal; 2024 Oct; 122():111341. PubMed ID: 39121974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLRC5 deficiency selectively impairs MHC class I- dependent lymphocyte killing by cytotoxic T cells.
    Staehli F; Ludigs K; Heinz LX; Seguín-Estévez Q; Ferrero I; Braun M; Schroder K; Rebsamen M; Tardivel A; Mattmann C; MacDonald HR; Romero P; Reith W; Guarda G; Tschopp J
    J Immunol; 2012 Apr; 188(8):3820-8. PubMed ID: 22412192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NLRC5 promotes cell migration and invasion by activating the PI3K/AKT signaling pathway in endometrial cancer.
    Fan Y; Dong Z; Shi Y; Sun S; Wei B; Zhan L
    J Int Med Res; 2020 May; 48(5):300060520925352. PubMed ID: 32431202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells.
    Guo X; Liu T; Shi H; Wang J; Ji P; Wang H; Hou Y; Tan RX; Li E
    J Virol; 2015 Aug; 89(15):7636-45. PubMed ID: 25972545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRC5 Might Promote Endometrial Cancer Progression by Inducing PD-L1 Expression.
    Zhu SD; Zhang J; Liu XJ; Zhang JH; Wei B; Wang WY; Fan YJ; Li D; Cao YX; Zhan L
    Technol Cancer Res Treat; 2022; 21():15330338221112742. PubMed ID: 35880269
    [No Abstract]   [Full Text] [Related]  

  • 16. LATS1/2 loss promote tumor immune evasion in endometrial cancer through downregulating MHC-I expression.
    Yang Q; Lv Z; Wang M; Kong M; Zhong C; Gao K; Wan X
    J Exp Clin Cancer Res; 2024 Feb; 43(1):54. PubMed ID: 38383447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMI1 induces ubiquitination and protein degradation of Nod-like receptor family CARD domain containing 5 and suppresses human leukocyte antigen class I expression to induce immune escape in non-small cell lung cancer.
    Lu ZH; Tu GJ; Fu SL; Shang K; Peng SJ; Chen L; Gu XJ
    Kaohsiung J Med Sci; 2022 Dec; 38(12):1190-1202. PubMed ID: 36194200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLRC5/MHC class I transactivator is a target for immune evasion in cancer.
    Yoshihama S; Roszik J; Downs I; Meissner TB; Vijayan S; Chapuy B; Sidiq T; Shipp MA; Lizee GA; Kobayashi KS
    Proc Natl Acad Sci U S A; 2016 May; 113(21):5999-6004. PubMed ID: 27162338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promotion on NLRC5 upregulating MHC-I expression by IFN-γ in MHC-I-deficient breast cancer cells.
    Zhao MZ; Sun Y; Jiang XF; Liu L; Liu L; Sun LX
    Immunol Res; 2019 Dec; 67(6):497-504. PubMed ID: 31900803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLR family CARD domain containing 5 promotes hypoxia-induced cancer progress and carboplatin resistance by activating PI3K/AKT via carcinoembryonic antigen related cell adhesion molecule 1 in non-small cell lung cancer.
    Dong Y; Xu T; Li D; Guo H; Du X; Li G; Chen J; Wang B; Wang P; Yu G; Zhao X; Xue R
    Bioengineered; 2022 Jun; 13(6):14413-14425. PubMed ID: 36694434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.